Sort by
Refine Your Search
-
Category
-
Field
-
both at the individual and patient group level. Medical Priority Bleeding and Hemostasis The medical priority Bleeding and Hemostasis is an international frontrunner in applying state-of-the-art mass
-
frontrunner in applying state-of-the-art mass spectrometry-based proteomics in the area of benign hematology. We are a vibrant, international group of 35-40 colleagues (consisting of group leaders, postdocs
-
) formation, with a focus on its meaning in inflammatory disease. Although the scientific literature on this theme is full of supposed associations of NETs and mechanisms of disease, in reality there is little
-
several different techniques to characterize these HSCs, evaluating their genetic traits (using state-of-the-art omics analysis) but also their functionality (capacity to self-renewal and generate different